Concepedia

Thomas Kaelin

TK

3

Publications

364

Citations

3

H-Index

2010

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Thomas Kaelin is an author at GlaxoSmithKline (United States) specializing in anesthesiology, medicine, and pharmacotherapy.

Top concepts

Publications per year

2010–2014

3

Publications

3

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials

Marc Decramer, Antonio Anzueto, Edward Kerwin et al. · The Lancet Respiratory Medicine · 2014 · 231 citations

, , +6

Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial

M. Reza Maleki-Yazdi, Thomas Kaelin, Nathalie Richard et al. · Respiratory Medicine · 2014 · 117 citations · Full text

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat® inhaler versus MDI

Richard ZuWallack, María Cristina De Salvo, Thomas Kaelin et al. · Respiratory Medicine · 2010 · 16 citations · Full text

, , +2

Rows per page

1–3 of 3